Objectives: Few population-based studies have compared risk factors related to chronic diseases across multiethnic groups of Chinese people. Consequently, we report the prevalence of common chronic disorders that make up the metabolic syndrome and compare their distribution in three ethnic subgroups: the offspring of Hakka, Minnan, and mainlander women.

Methods: We included 6854 participants in the Li-Shin Outreaching Neighborhood Screening (LIONS) project: 3088 (45.1%) Hakkas, 2461 (35.9%) Minnans, and 1305 (19.0%) mainlanders. Information on demographic features and recognized lifestyle factors was collected by using questionnaires; data on biological markers of metabolic syndrome were collected from serum samples by using standard biochemical analyses.

Results: Miscegenation averaged 22%. Smoking, alcohol consumption, and betel chewing varied across the three subpopulations. After controlling for demographic features and these three risk factors, men with mainlander mothers had more body fat. Compared with offspring with Hakka mothers, attendees whose mothers were from Minnan had higher uric acid concentrations.

Conclusions: Despite the rarity of racial miscegenation in the three ethnic groups, most biological markers of metabolic syndrome were identical across the groups. Disparities were found for hyperuricemia in attendees whose mothers were from Minnan and for obesity in men whose mothers were mainlanders. These findings can help design health policy for the early detection of chronic disease in different ethnic Chinese groups.

Download full-text PDF

Source

Publication Analysis

Top Keywords

risk factors
12
three ethnic
12
metabolic syndrome
12
chronic disease
8
ethnic groups
8
li-shin outreaching
8
outreaching neighborhood
8
neighborhood screening
8
screening lions
8
offspring hakka
8

Similar Publications

Background: Genetic studies indicate a causal role for microglia, the innate immune cells of the central nervous system (CNS), in Alzheimer's disease (AD). Despite the progress made in identifying genetic risk factors, such as CD33, and underlying molecular changes, there are currently limited treatment options for AD. Based on the immune-inhibitory function of CD33, we hypothesize that inhibition of CD33 activation may reverse microglial suppression and restore their ability to resolve inflammatory processes and mitigate pathogenic amyloid plaques, which may be neuroprotective.

View Article and Find Full Text PDF

Background: Cerebral small vessel disease (CSVD) is one of the most common nervous system diseases. Hypertension and neuroinflammation are considered important risk factors for the development of CSVD and white matter (WM) lesions.

Method: We used the spontaneously hypertensive rat (SHR) as a model of early-onset CSVD and administered epimedium flavonoids (EF) for three months.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB, Canada.

Background: Alzheimer's disease (AD) is a neurodegenerative disorder primarily associated with aging, but manifests as a complex interplay of multiple factors. Decline in sex-hormones, particularly 17-beta estradiol, is linked to the aging process. The risk for onset of AD significantly increases with aging and loss of estradiol.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease and the most common form of dementia. Although AD is characterized by the accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles (NFTs), it's estimated that nearly half of AD cases might be attributed to modifiable risk factors and lifestyle-based interventions may offer promising preventative strategies to delay disease onset and progression. Polyphenolic derivatives easily found in foods like luteolin and curcumin have shown beneficial effects to counteract cognitive decline.

View Article and Find Full Text PDF

Background: The effectiveness of multimodal lifestyle interventions to prevent dementia is being validated. Since a relatively long period (∼2 years) is required for manifesting an impact on cognitive function, the exploration of an alternative marker that exhibits changes within a comparatively brief duration, thereby prognosticating future alterations in cognitive function, is needed. The decline in gait function is associated with cognitive impairment and is also a predictor of future cognitive decline.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!